(Q27000732)

language of work or name

1 reference

October 2014

1 reference

Annals of the New York Academy of Sciences

1 October 2014

8 references

19 March 2019

25 June 2019

30 May 2020

13 July 2020

2 October 2020

14 November 2020

31 July 2022

4 October 2022

9 references

19 March 2019

25 June 2019

30 May 2020

13 July 2020

2 October 2020

14 November 2020

31 July 2022

4 October 2022

1327

1 reference

page(s)

112-30

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

copyright license

8 references

19 March 2019

25 June 2019

30 May 2020

13 July 2020

2 October 2020

14 November 2020

31 July 2022

on focus list of Wikimedia project

4 October 2022

ScienceSource

0 references

cites work

Measuring the global burden of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Oral naltrexone maintenance treatment for opioid dependence

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Association between alcohol consumption and both osteoporotic fracture and bone density

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Integrating primary medical care with addiction treatment: a randomized controlled trial

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The quality of health care delivered to adults in the United States

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Financial factors and the implementation of medications for treating opioid use disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Drug policy and the public good: evidence for effective interventions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Economic costs of excessive alcohol consumption in the U.S., 2006.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Strategies for evaluating the economic value of drugs in alcohol dependence treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

A literature review of cost-benefit analyses for the treatment of alcohol dependence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Substance use: impact on adherence and HIV medical treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost and utilization outcomes of opioid-dependence treatments.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Adoption and implementation of medications in addiction treatment programs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Comparison of healthcare utilization among patients treated with alcoholism medications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Intramuscular extended-release naltrexone: current evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

HEE-GER: a systematic review of German economic evaluations of health care published 1990-2004

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Trends in the adoption of medications for alcohol dependence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost methodology of COMBINE.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

A review of uses of health care utilization databases for epidemiologic research on therapeutics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The prevalence and impact of alcohol problems in major depression: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Adherence to pharmacotherapy in patients with alcohol and opioid dependence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Impact of the heroin 'drought' on patterns of drug use and drug-related harms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Effect of alcohol consumption on diabetes mellitus: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost-benefit analysis of drug treatment services: review of the literature*

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Buprenorphine for opiate addiction: potential economic impact

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The cost-effectiveness of methadone maintenance.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The cross-cultural validity of self-reported use of health care: a comparison of survey and registration data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The cost-effectiveness of methadone maintenance as a health care intervention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The cost-effectiveness of treatment for alcoholism: a second approximation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

The cost effectiveness of treatment for alcoholism: a first approximation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Methadone maintenance and state Medicaid managed care programs.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls

31 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Risk factors associated with antihypertensive medication nonadherence in a statewide Medicaid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Datapoints: Trends in naltrexone use among members of a large private health plan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Economic evaluation of interventions for problem drinking and alcohol dependence: do within-family external effects make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Measuring use of health services for at-risk drinkers: how brief can you get?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Availability of medical care services in drug treatment clinics associated with lower repeated emergency department use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

The effect of alcoholism treatment on medical care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

HIV transmission and the cost-effectiveness of methadone maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Office-based treatment for opioid addiction achieving goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Comparison of costs and utilization among buprenorphine and methadone patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Treatment for drug abuse. Follow-up outcomes and length of time spent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

As roughly 700,000 prisoners are released annually, about half will gain health coverage and care under federal laws.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Seizing opportunities under the Affordable Care Act for transforming the mental and behavioral health system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12538

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Utilization patterns of extended-release naltrexone for alcohol dependence.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4206699

Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25236185